Affordable Access

Publisher Website

Interaction between basic fibroblast growth factor and the anti-angiogenic drug PNU145156E

Authors
Journal
Journal of Molecular Structure
0022-2860
Publisher
Elsevier
Publication Date
Identifiers
DOI: 10.1016/j.molstruc.2006.03.062
Keywords
  • Angiogenesis
  • Cancer
  • Suradista
  • Naphthalene Sulfonic Distamycin A Derivatives
  • Heparin-Binding Growth Factors
  • Bfgf
  • Fluorescence Spectroscopy
Disciplines
  • Biology

Abstract

Abstract Solid tumors require the formation of a vascular network derived from host blood vessels to support their growth. The heparin-binding growth factor family was the first class of angiogenesis factors to be studied. These proteins play key roles in a variety of crucial biological activities that require cell growth, differentiation, migration and chemotaxis. Our work presents the study of a group of polyanionic compounds, the naphthalene sulfonic distamycin A derivatives, named suradistas, which represents a new class of inhibitors of neo-angiogenesis that can counteract vascularization of solid tumors. By a combination of in vitro and in vivo approaches, a leader compound, PNU145156E, was selected. The results suggest that PNU145156E interacts directly with the heparin-binding growth factor bFGF in a specific manner. It forms a tight but reversible 1 to 1 complex with the protein, inducing conformational changes, which render bFGF less stable, preventing the interaction with heparin and the biologically effective dimerization of the growth factor.

There are no comments yet on this publication. Be the first to share your thoughts.